Comparing two ovarian stimulation methods for women with low egg response
Part of Women’s health & pregnancy clinical trials.
This trial compares two different ways of stimulating the ovaries in women who have a poor response to fertility treatment. It aims to see which method gives a higher chance of having a live baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 44 years old.
- You have a body mass index (BMI) between 19 and 32 – a measure of weight for height.
- You have been diagnosed with poor ovarian response, meaning your ovaries do not respond well to fertility medications.
- You have had no more than two previous IVF cycles.
- You do not have a partner with very severe sperm problems, and you are not using donor sperm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
This trial compares dydrogesterone with a GnRH antagonist to see which works better for women with a low number of eggs (poor responders) who are undergoing two rounds of egg retrieval in one cycle. It may help improve outcomes for those with specific fertility challenges.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This trial tests whether giving the hormone that triggers ovulation in two doses is better than one dose for people who over-respond to fertility treatment. It is designed for those having in vitro fertilization (IVF) with a GnRH antagonist protocol.
This study compares two ways of giving fertility medication to stimulate the ovaries before retrieving eggs for IVF (in vitro fertilization). One method starts after ovulation and uses a drug called Elonva without a routine blocking medication, while the other is the standard approach starting early in the cycle. The goal is to see which approach leads to better outcomes for people undergoing IVF or ICSI (a procedure where a single sperm is injected into an egg).
This trial compares two types of ovarian stimulation protocols (PPOS and antagonist) for women with PCOS undergoing IVF to see which leads to better outcomes. If you have PCOS and are planning IVF, this study may help find the best approach for you.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.